Quarterly report pursuant to Section 13 or 15(d)

Marketable Equity Securities - Schedule of Investments in Marketable Equity Securities (Details)

v3.8.0.1
Marketable Equity Securities - Schedule of Investments in Marketable Equity Securities (Details)
Mar. 31, 2018
USD ($)
Schedule Of Available For Sale Securities [Line Items]  
Cost Basis $ 755,487
Gross Unrealized Gains 754,696
Value 1,510,183
Common stocks  
Schedule Of Available For Sale Securities [Line Items]  
Cost Basis 755,487
Gross Unrealized Gains 754,696
Value $ 1,510,183